The stock of Akers Biosciences Inc (NASDAQ:AKER) is a huge mover today! About 150,905 shares traded hands or 589.73% up from the average. Akers Biosciences Inc (NASDAQ:AKER) has risen 72.41% since April 14, 2016 and is uptrending. It has outperformed by 67.73% the S&P500.
The move comes after 8 months negative chart setup for the $16.36 million company. It was reported on Nov, 16 by Barchart.com. We have $2.02 PT which if reached, will make NASDAQ:AKER worth $2.13 million less.
According to Zacks Investment Research, “Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company’s products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.”
More recent Akers Biosciences Inc (NASDAQ:AKER) news were published by: Marketwatch.com which released: “Akers Biosciences halves loss; revenue up 262%” on November 14, 2016. Also Quotes.Wsj.com published the news titled: “News Akers Biosciences Inc.AKER” on January 24, 2014. Streetinsider.com‘s news article titled: “Akers Biosciences (AKER) Receives European Patent Covering Breath Ketone Detector” with publication date: November 10, 2016 was also an interesting one.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.